ABI-009

Overview

ABI-009 is an inhibitor of an overactive biological pathway in the cancer cells.

SparkCures ID 319
Developed By Aadi Bioscience, Inc.
Generic Name ABI-009
Additional Names nab-rapamycin
Treatment Classifications
  • Mammalian Target of Rapamycin (mTOR) Inhibitor

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.